Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1966 1
1968 3
1969 1
1970 5
1971 7
1972 5
1973 13
1974 6
1975 4
1976 1
1977 3
1978 3
1979 7
1980 4
1981 4
1982 6
1983 5
1984 7
1985 15
1986 7
1987 5
1988 7
1989 12
1990 4
1991 4
1992 6
1993 5
1994 4
1995 8
1996 4
1997 6
1998 7
1999 2
2000 10
2001 4
2002 11
2003 17
2004 24
2005 21
2006 26
2007 20
2008 35
2009 36
2010 38
2011 53
2012 96
2013 88
2014 90
2015 76
2016 83
2017 94
2018 127
2019 126
2020 163
2021 192
2022 187
2023 189
2024 235
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,025 results

Results by year

Filters applied: . Clear all
Page 1
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C. Marty FM, et al. Among authors: haider s. N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6. N Engl J Med. 2017. PMID: 29211658 Free article. Clinical Trial.
Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
Papanicolaou GA, Avery RK, Cordonnier C, Duarte RF, Haider S, Maertens J, Peggs KS, Solano C, Young JH, Fournier M, Murray RA, Wu J, Winston DJ; AURORA Trial Investigators. Papanicolaou GA, et al. Among authors: haider s. Clin Infect Dis. 2024 Mar 20;78(3):562-572. doi: 10.1093/cid/ciad709. Clin Infect Dis. 2024. PMID: 38036487 Free PMC article. Clinical Trial.
Tricine-SDS-PAGE.
Haider SR, Reid HJ, Sharp BL. Haider SR, et al. Methods Mol Biol. 2012;869:81-91. doi: 10.1007/978-1-61779-821-4_8. Methods Mol Biol. 2012. PMID: 22585479
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response.
Bland P, Saville H, Wai PT, Curnow L, Muirhead G, Nieminuszczy J, Ravindran N, John MB, Hedayat S, Barker HE, Wright J, Yu L, Mavrommati I, Read A, Peck B, Allen M, Gazinska P, Pemberton HN, Gulati A, Nash S, Noor F, Guppy N, Roxanis I, Pratt G, Oldreive C, Stankovic T, Barlow S, Kalirai H, Coupland SE, Broderick R, Alsafadi S, Houy A, Stern MH, Pettit S, Choudhary JS, Haider S, Niedzwiedz W, Lord CJ, Natrajan R. Bland P, et al. Among authors: haider s. Nat Genet. 2023 Aug;55(8):1311-1323. doi: 10.1038/s41588-023-01460-5. Epub 2023 Jul 31. Nat Genet. 2023. PMID: 37524790 Free PMC article.
Injectable contraception.
Haider S, Darney PD. Haider S, et al. Clin Obstet Gynecol. 2007 Dec;50(4):898-906. doi: 10.1097/GRF.0b013e318159c20a. Clin Obstet Gynecol. 2007. PMID: 17982332 Review.
2,025 results